Clomifene (previously clomiphene) is an orally administered, non steroidal, ovulatory stimulant that acts as a selective estrogen receptor modulator (SERM). Clomifene can lead to multiple ovulation, and hence increase the risk of conceiving twins. Clomifene, also known as clomiphene, is a medication used to treat infertility in women who do not ovulate, including those with polycystic ovary syndrome.

Understanding the Context

[5] Clomiphene was a revolutionary advance in reproductive medicine and quickly became popular for induction of ovulation because of its ease of administration and minimal side effects. Clomiphene citrate acts as a selective estrogen receptor modulator (SERM), which means it binds to estrogen receptors in various parts of the body, including the hypothalamus, ovaries, endometrium, and cervix. Emphasizing the interprofessional approach to patient care, the program delves into the nuanced considerations surrounding clomiphene therapy, including indications, mechanisms of action, optimal administration, potential adverse effects, contraindications, and crucial monitoring strategies. Clomiphene is a racemic mixture consisting of zuclomiphene (~38%) and enclomiphene (~62%), each with distinct pharmacologic properties.

Key Insights

Clomiphene acts at the level of the hypothalamus, occupying cell surface and intracellular estrogen receptors (ERs) for longer durations than estrogen. clomiPHENE reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI). Clomiphene is a non-steroidal fertility medicine. It causes the pituitary gland to release hormones needed to stimulate ovulation (the release of an egg from the ovary).